Toulon Pierre, Berruyer Micheline, Brionne-François Marie, Grand François, Lasne Dominique, Telion Caroline, Arcizet Julien, Giacomello Roberta, De Pooter Neila
Dr. Pierre Toulon, CHU Nice, Hôpital Pasteur, Service d'Hématologie Biologique, 30, avenue de la Voie Romaine, CS 51069, F-06001 Nice Cedex 1, France, Tel.: + 33 4 92 03 87 09, Fax: + 33 4 92 03 85 95, E-mail:
Thromb Haemost. 2016 Jul 4;116(1):9-16. doi: 10.1160/TH15-12-0964. Epub 2016 Mar 17.
Understanding of developmental haemostasis is critical to ensure optimal prevention, diagnosis, and treatment of haemorrhagic and thrombotic diseases in children. As coagulation test results are known to be dependent on the reagents/analysers used, it is recommended for each laboratory to define the age-dependent reference ranges by using its own technical condition. That study was carried out in seven centers to establish age-specific reference ranges using the same reagents and analyser. Plasma samples were obtained from 1437 paediatric patients from the following age groups: 15 days-4 weeks (n=36), 1-5 months (n=320), 6-12 months (n=176), 1-5 years (n=507), 6-10 years (n=132) and 11-17 years (n=262). Indication of coagulation testing was pre-operative screening for non-acute diseases in most cases. PT values were similar in the different age groups to those in adults, whereas longer aPTTs were demonstrated in the younger children. Plasma levels of all clotting factors, except for FV, were significantly decreased (p<0.0001) in the youngest children, adult values being usually reached before the end of the first year. The same applied to antithrombin, protein C/S, and plasminogen. In contrast, FVIII and VWF levels were elevated in the youngest children and returned to adult values within six months. The same applied to D-dimer levels, which were found elevated, particularly until six months of life, until puberty. These data suggest that most coagulation test results are highly dependent on age, mainly during the first year of life, and that age-specific reference ranges must be used to ensure proper evaluation of coagulation in children.
了解发育性止血对于确保儿童出血性和血栓性疾病的最佳预防、诊断和治疗至关重要。由于已知凝血检测结果取决于所使用的试剂/分析仪,建议每个实验室根据自身技术条件确定年龄相关的参考范围。该研究在七个中心进行,使用相同的试剂和分析仪建立特定年龄的参考范围。从1437名儿科患者中采集血浆样本,这些患者来自以下年龄组:15天至4周(n = 36)、1至5个月(n = 320)、6至12个月(n = 176)、1至5岁(n = 507)、6至10岁(n = 132)和11至17岁(n = 262)。在大多数情况下,凝血检测的指征是对非急性疾病进行术前筛查。不同年龄组的PT值与成人相似,而年幼儿童的aPTT较长。除FV外,所有凝血因子的血浆水平在最年幼儿童中均显著降低(p<0.0001),通常在第一年末达到成人水平。抗凝血酶、蛋白C/S和纤溶酶原也是如此。相比之下,FVIII和VWF水平在最年幼儿童中升高,并在六个月内恢复到成人水平。D - 二聚体水平也是如此,发现其升高,尤其是在生命的前六个月直至青春期。这些数据表明,大多数凝血检测结果高度依赖于年龄,主要是在生命的第一年,并且必须使用特定年龄的参考范围来确保对儿童凝血功能进行正确评估。